Argenx SE receives 'buy' recommendations from 22 firms, with Wells Fargo raising target price

Summary

Argenx SE (NASDAQ:ARGX) has received a consensus ‘Buy’ recommendation from 22 brokerages, with 20 analysts rating it as a buy and 2 as a strong buy. The average 12-month target price is $766.50. Recent upgrades include Wells Fargo raising its target to $756.00 and JPMorgan increasing it to $830.00. The stock opened at $712.20, with a market cap of $43.59 billion and a PE ratio of 36.52. Argenx reported $3.74 EPS for the last quarter, exceeding estimates, and had a revenue of $866.79 million.Market Beat

Impact Analysis

So basically, Argenx SE is riding a wave of positive sentiment from the analyst community, with 22 brokerages giving it a ‘Buy’ recommendation. The interesting part isn’t just the consensus, but the fact that heavyweights like Wells Fargo and JPMorgan have significantly raised their target prices to $756 and $830, respectively. This suggests a strong belief in Argenx’s growth trajectory, likely driven by its recent earnings beat and robust revenue figures. The market might be underestimating the potential upside here, especially with the stock opening at $712.20, which is below the average target price of $766.50. The PE ratio of 36.52 indicates that investors are willing to pay a premium for its growth prospects. I’d read this as a signal that Argenx could see further stock appreciation, particularly if it continues to outperform earnings expectations. Keep an eye on how the market digests these upgrades and whether it triggers a broader re-rating of the stock.Market Beat